Valuation: Haleon plc

Market Cap 32.23B 43.12B 37.78B 35.08B 60.74B 4,161B 61.63B 418B 164B 2,036B 162B 158B 7,034B P/E 2026 *
18.9x
P/E 2027 * 17.1x
Enterprise Value 39.15B 52.37B 45.89B 42.6B 73.76B 5,054B 74.85B 507B 199B 2,473B 197B 192B 8,542B EV / Sales 2026 *
3.43x
EV / Sales 2027 * 3.25x
Free-Float
99.42%
Yield 2026 *
2.18%
Yield 2027 * 2.43%
1 day-1.65%
1 week-3.00%
Current month+3.25%
1 month+7.58%
3 months+2.10%
6 months-5.48%
Current year-4.22%
1 week 358.4
Extreme 358.4
377.5
1 month 336.9
Extreme 336.9
377.5
Current year 317.8
Extreme 317.8
416.1
1 year 274.4
Extreme 274.4
416.1
3 years 274.4
Extreme 274.4
419.5
5 years 241.17
Extreme 241.1735
419.5
10 years 241.17
Extreme 241.1735
419.5
Manager TitleAgeSince
Chief Executive Officer 59 2021-07-21
Director of Finance/CFO 57 2024-10-31
Chief Tech/Sci/R&D Officer 63 2025-07-31
Director TitleAgeSince
Director/Board Member 59 2022-05-22
Chairman 71 2025-12-31
Director/Board Member 59 2022-07-17
Date Insider Type Main position Quantity % Market Cap.
6/30/26 Tax

Chief Financial Officer

-133,301 0.0015%
6/30/26 Free

Chief Financial Officer

283,193 0.0032%
5/19/26 Buy

Chief Financial Officer

2,596 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-1.60%-3.00%+0.14%+6.75% 43.12B
+1.80%+0.86%+47.61%+156.73% 1,037B
+0.84%+2.96%+52.19%+50.43% 615B
+1.50%+0.87%+34.66%+79.21% 448B
+5.70%+5.43%+33.79%+27.82% 326B
+1.55%+2.58%+35.78%+39.25% 293B
-0.42%-0.24%+18.03%+16.86% 264B
+0.42%-4.68%-27.71%-41.80% 216B
+0.64%-1.25%+18.67%+55.87% 198B
-0.08%-5.04%+13.97%+66.66% 162B
Average +0.98%+1.20%+22.71%+45.78% 360.06B
Weighted average by Cap. +1.44%+1.48%+34.22%+74.19%

Financials

2026 *2027 *
Net sales 11.4B 15.25B 13.36B 12.41B 21.48B 1,472B 21.8B 148B 57.84B 720B 57.25B 56.02B 2,488B 11.89B 15.91B 13.94B 12.94B 22.41B 1,535B 22.74B 154B 60.33B 751B 59.72B 58.43B 2,595B
Net income 1.74B 2.33B 2.04B 1.9B 3.28B 225B 3.33B 22.6B 8.84B 110B 8.75B 8.57B 380B 1.9B 2.54B 2.23B 2.07B 3.58B 245B 3.63B 24.64B 9.65B 120B 9.55B 9.34B 415B
Net Debt 6.91B 9.25B 8.1B 7.52B 13.03B 893B 13.22B 89.63B 35.08B 437B 34.72B 33.97B 1,509B 6.4B 8.57B 7.51B 6.97B 12.07B 827B 12.25B 83.02B 32.5B 405B 32.16B 31.47B 1,398B
Logo Haleon plc
Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (29.5%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - Pain relief medicines (22.8%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - medicines for digestive health (17.7%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - vitamins, minerals and food supplements (15.1%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc. - respiratory medicines (14.9%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (41.2%), North America (36%), and Asia/Pacific (22.8%).
Employees
24,535
Date Price Change Volume
26-07-23 GBX 359.30 -1.80% 4,246,053
26-07-22 GBX 365.90 -0.73% 20,492,365
26-07-21 GBX 368.60 -0.65% 23,392,432
26-07-20 GBX 371.00 -0.62% 18,087,141
26-07-17 GBX 373.30 +0.86% 20,562,834
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
3.659GBP
Average target price
4.142GBP
Spread / Average Target
+13.21%

Quarterly revenue - Rate of surprise